TORONTO, Ontario (PRWEB)
May 24, 2023
The process of transforming and analyzing clinical trial data can be challenging for pharmaceutical companies, biotechs, and CROs. A number of issues, including disjointed systems, high IT costs, and lengthy installation times, can lead to financial losses. Furthermore, if users make mistakes and need to start again, this can prove to be time-consuming and resource-intensive.
To address common challenges in the biometric area, Chris Decker and John Leveille from Instem will host a live webinar on June 12 to demonstrate how a cloud-based statistical computing environment (SCE) can provide a centralized compliance, analysis, and submission solution. The SCE comes preloaded and validated with tools, applications, and licenses for pharmaceutical companies and CROs of all sizes. Using a cloud-based SCE, users can share data, programs, and analysis results, which can increase efficiency and reduce costs.
During the webinar, attendees will gain an overview of the benefits of a cloud-based SCE, learn how programmers and statisticians can leverage different tools to improve their processes, see a preview of an enhanced cloud-enabled platform for managing biometric workflow, and have the opportunity to ask questions.
The live webinar will take place on June 12, 2023, at 2 pm EDT (11 am PDT). Speakers at the event include Chris Decker, VP Clinical Solutions, Instem; John Leveille, Executive Vice President, Clinical Trial Acceleration, Instem. Register for the event here.
Xtalks, which is powered by Honeycomb Worldwide Inc., hosts educational webinars for professionals in the global life science, food, and medical device community. Each year, thousands of industry practitioners from life science, food, and medical device companies, as well as private and academic research institutions, healthcare centers, etc. turn to Xtalks for access to quality content.
For further information or to register for Xtalks webinars, visit http://xtalks.com.
Tel: +1 (416) 977-6555 x371
Share article on social media or email: